Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology. 2018;91(24):e2211-e2221. ... read more
Galcanezumab Safe, Effective for Reducing Monthly Migraine Headache Days
Galcanezumab Safe, Effective for Reducing Monthly Migraine Headache Days